Hologic Stock Forecast for 2023 - 2025 - 2030
Updated on 04/26/2024
Hologic Stock Forecast and Price Target
In recent months, three notable analysts have provided yearlong price targets for Hologic, with the average target coming in at $84.00. If it were to be achieved, this would result in a potential upside of approximately 10.95 percent from the most recent closing price in April, 2024. The high end is $95.00, and the low is $70.00. If you're interested in HOLX stock, it's important to compare it to other companies in the industry.
10.95% Upside
Hologic Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Hologic's Price has decreased from $59.62 to $0.00 – a 100.00% drop. Analysts predict that Hologic's Fair Value will increase in the upcoming year, reaching $64.11. This would represent an increase of 100.00%. Over the next seven years, experts predict that Hologic's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| NOVN Stock Forecast | Novartis | Hold |
10
|
CHF90.00 | Buy/Sell | CHF105.00 | 19.58% |
| ROG Stock Forecast | Roche Holding | Hold |
16
|
CHF218.80 | Buy/Sell | CHF307.83 | 24.54% |
| DHR Stock Forecast | Danaher | Outperform |
10
|
$245.80 | Buy/Sell | $260.33 | 9.85% |
| ABT Stock Forecast | Abbott Laboratories | Outperform |
9
|
$106.86 | Buy/Sell | $118.92 | 18.38% |
| GE Stock Forecast | General Electric | Outperform |
8
|
$161.26 | Buy/Sell | $144.00 | 11.62% |
Hologic Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Hologic's Revenue has seen an increase, rising from $3.78B to $4.03B. This represents a growth of 6.73%. Analysts predict that Hologic's Revenue will increase in the upcoming year, reaching $4.37B. This would represent an increase of 8.37%. Over the next seven years, experts predict that Hologic's Revenue will grow at a rate of 49.15%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PFE Stock Forecast | Pfizer | Outperform |
2
|
$25.26 | Buy/Sell | $32.87 | 20.74% |
| SIE Stock Forecast | Siemens | Outperform |
10
|
173.70€ | Buy/Sell | 178.14€ | 12.55% |
| ISRG Stock Forecast | Intuitive Surgical | Outperform |
13
|
$373.12 | Buy/Sell | $408.45 | 15.24% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BMY Stock Forecast | Bristol-Myers Squibb | Hold |
2
|
$44.70 | Buy/Sell | $58.15 | 21.92% |
| GSK Stock Forecast | GSK | Outperform |
12
|
£16.41 | Buy/Sell | £17.30 | 18.83% |
| BDX Stock Forecast | Becton Dickinson and Co | Outperform |
9
|
$230.48 | Buy/Sell | $284.47 | 21.49% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| EW Stock Forecast | Edwards Lifesciences Corp | Outperform |
11
|
$88.01 | Buy/Sell | $91.18 | 10.21% |
| IDXX Stock Forecast | IDEXX Laboratories | Outperform |
14
|
$489.24 | Buy/Sell | $583.92 | 22.64% |
| ALC Stock Forecast | Alcon | Outperform |
8
|
CHF71.56 | Buy/Sell | CHF90.64 | 34.66% |
Hologic EBITDA Forecast for 2023 - 2025 - 2030
Hologic's EBITDA has decreased by 16.43% In the last three years, from $1.53B to $1.28B. In the next year, analysts predict that EBITDA will reach $1.55B – an increase of 21.31%. For the next seven years, the forecast is for EBITDA to grow by 49.88%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A Stock Forecast | Agilent Technologies | Outperform |
10
|
$136.37 | Buy/Sell | $138.82 | 11.09% |
| RKT Stock Forecast | Reckitt Benckiser Group | Outperform |
12
|
£43.56 | Buy/Sell | £66.68 | 23.97% |
| RMD Stock Forecast | ResMed Inc | Outperform |
17
|
$183.42 | Buy/Sell | $201.32 | 11.77% |
Hologic EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Hologic's EBIT has decreased from $1.16B to $958.30M – a 17.22% drop! In the next year, analysts are expecting an increase in EBIT, predicting it will reach $1.45B – an increase of 51.10%. The Hologic forecast is for EBIT to reach $2.22B or grow by 132.10%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MTD Stock Forecast | Mettler-Toledo International | Hold |
13
|
$1.23k | Buy/Sell | $1.12k | -0.24% |
| SIEMENS Stock Forecast | Siemens | Outperform |
16
|
Rp5.73k | Buy/Sell | Rp4.02k | -15.23% |
| 4901 Stock Forecast | FUJIFILM Holdings | Buy |
18
|
¥9.41k | Buy/Sell | ¥10.57k | 9.43% |
Hologic EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Hologic's EPS has decreased from $3.98 to $0.00 – a 100.00% drop. Analysts predict that Hologic's EPS will increase in the upcoming year, reaching $4.28. This would represent an increase of 100.00%. Over the next seven years, experts predict that Hologic's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 7751 Stock Forecast | Canon | Hold |
18
|
¥4.28k | Buy/Sell | ¥3.74k | -11.24% |
| STE Stock Forecast | STERIS | Outperform |
13
|
$201.54 | Buy/Sell | $238.33 | 19.58% |
| PHIA Stock Forecast | Koninklijke Philips N.V. | Hold |
18
|
19.27€ | Buy/Sell | 19.42€ | 1.19% |
.jpg)